Gosset Ownership
Private
Therapeutic Areas
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Bioniche Pharma General Information
Bioniche Pharma was a leading developer and manufacturer of branded and generic injectable pharmaceuticals for hospital and primary care markets. As of its acquisition by Mylan in 2010, it had over 30 marketed products across several therapeutic areas with significant investments in its pipeline including at least 15 ANDAs pending FDA approval and more than 25 additional products in development. Most sales were derived from the U.S. market.
Contact Information
Website
Primary Industry
Biotech
Corporate Office
Galway, County Galway
Ireland
Ireland
Drug Pipeline
No pipeline data available
Key Partnerships
RoundTable Healthcare Partners was the private equity owner prior to Mylan’s acquisition
Bioniche Pharma Funding
No funding data available
To view Bioniche Pharma's complete valuation and funding history, request access »